Financiële vergelijkingen Enanta Pharmaceuticals, Inc.
Aandelen
ENTA
US29251M1062
Farmaceutische producten
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 14,60 USD | +3,62% |
|
+3,40% | +153,91% |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Omzet (Y-1) | Nettomarge (Y-1) | Ebit-marge (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | |
|---|---|---|---|---|---|---|---|
 | 65,32 mln. | -125,36% | -130,65% | -75,6% | -25,5% | -0.69x | |
| 14,2 mld. | 31,07% | 36,7% | 19,23% | 15,02% | -1.11x | |
| 15,56 mld. | 19,3% | 28,72% | 16,36% | 7,75% | 1.74x | |
| 6,37 mld. | 17,31% | 13,59% | 11,21% | 6,48% | 0.99x | |
| 3,08 mld. | 23,82% | 29,03% | 10,45% | 6,49% | 0.1x | |
| 9,68 mld. | 16,87% | 31,16% | 10,36% | 5,95% | 1.06x | |
| 1,29 mld. | -1% | -8,02% | -0,74% | -0,45% | -11.4x | |
| 4,24 mld. | 0,77% | 9,76% | 5,27% | 3,72% | -4.29x | |
| 69,63 mln. | 59,01% | 24,7% | 28,77% | 18,72% | -6.16x | |
| 222 mln. | -241,44% | -267,22% | 35,11% | -73,11% | -1.77x | |
| 681 mln. | -10,97% | -17,14% | -8,58% | -7,13% | 8.63x | |
| 2,35 mld. | 14,93% | 22,42% | 10,9% | 5,41% | 1.59x | |
| 3,24 mld. | -110,04% | -121,91% | -28,77% | -21,87% | 1.87x | |
| 10,9 mln. | -2.957,71% | -3.477,43% | -33,47% | - | 3.99x | |
| 2,85 mld. | 14,96% | 16,97% | 8,05% | 6,17% | -0.93x | |
| 1,25 mld. | 22,95% | 28,06% | 14,19% | 8,74% | 0.28x | |
| 308 mln. | 4,73% | 4,18% | 0,85% | - | -5.29x | |
| 7,47 mld. | 2,18% | 18,81% | 2,79% | 0,74% | 5.16x | |
| 386 mln. | -74,47% | -72,74% | -231,63% | -49,66% | 0.49x | |
| Gemiddelde | 3,86 mld. | -173,32% | -201,63% | -10,8% | -5,44% | -0,30x | |
| Gewogen gemiddelde per kap. | 7,06 mld. | -69,32% | -81,03% | 6,27% | 3,04% | -0,33x |
- Beurs
- Aandelen
- Koers ENTA
- Sector Enanta Pharmaceuticals, Inc.
- Financiële vergelijkingen
Kies jouw editie
Alle financiële informatie op nationaal niveau
